A prophylactic α-Gal-based glycovaccine effectively protects against murine acute Chagas disease
2019 · npj Vaccines · 58 citations
https://doi.org/10.1038/s41541-019-0107-7
E
Eva Iniguez
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
43
Papers
602
Citations
13
h-index
15
i10-index
Eva Iniguez is an academic researcher from National Institute of Allergy and Infectious Diseases. The author has contributed to research in topics: Research on Leishmaniasis Studies & Trypanosoma species research and implications & Synthesis and Biological Evaluation. The author has an h-index of 13, co-authored 37 publications.
ORCID: 0009-0006-9027-0523Papers by this author
worksHeme Oxygenase-1 Induction by Blood-Feeding Arthropods Controls Skin Inflammation and Promotes Disease Tolerance
2020 · Cell Reports · 20 citations
https://doi.org/10.1016/j.celrep.2020.108317
Towards a Sustainable Vector-Control Strategy in the Post Kala-Azar Elimination Era
2021 · Frontiers in Cellular and Infection Microbiology · 19 citations
https://doi.org/10.3389/fcimb.2021.641632
The impact of blood on vector-borne diseases with emphasis on mosquitoes and sand flies
2025 · Trends in Parasitology · 11 citations
https://doi.org/10.1016/j.pt.2025.01.009
Leishmania sand fly-transmission is disrupted by Delftia tsuruhatensis TC1 bacteria
2025 · Nature Communications · 11 citations
https://doi.org/10.1038/s41467-025-58769-4
Salivary antigens rPagSP02 and rPagSP06 are a reliable composite biomarker for evaluating exposure to Phlebotomus argentipes in Sri Lanka
2024 · Scientific Reports · 2 citations
https://doi.org/10.1038/s41598-024-77666-2
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat